Melanie Gauthier

1 Rue Du Pr Marion
Dijon, 21079, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.

NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy.

Journal: Cell death and differentiation

Published: August 31, 2016

Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer.

Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer.

Journal: Radiation oncology (London, England)

Published: February 10, 2016

Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.

Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: November 23, 2015

The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB

The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB

Journal: Bulletin du cancer

Published: September 22, 2014

Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM).

Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM).

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 25, 2014

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.

Journal: PloS one

Published: April 08, 2014

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 16, 2013

Impact of response shift on time to deterioration in quality of life scores in breast cancer patients.

Impact of response shift on time to deterioration in quality of life scores in breast cancer patients.

Journal: PloS one

Published: September 06, 2013

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study.

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study.

Journal: BMC cancer

Published: July 02, 2013

Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.

Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 27, 2013

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Journal: Radiation oncology (London, England)

Published: May 15, 2012

Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.

Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 21, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026